Skip to main content

A tale of caution: prolonged Bacillus clausii bacteraemia after probiotic use in an immunocompetent child

  • 2021-03-01
  • Access Microbiology 3(3)
    • A. Khatri
    • S. Rai
    • C. Shank
    • A. McInerney
    • B. Kaplan
    • Stefan H F Hagmann
    • Mundeep K Kainth

Abstract

Introduction: Bacillus clausii as a probiotic supplement is increasingly used in both adult and paediatric patient populations. There is limited awareness about potential adverse effects.

Case presentation: We report a case of prolonged (111 days) B. clausii bacteraemia after brief probiotic use in a 17-month-old immunocompetent child, without a definite focus of infection and in the absence of predisposing risk factors or underlying co-morbidities. We identified seven probiotic use-associated cases of prolonged B. clausii bacteraemia (mean duration [range] 64 days [14-93 days] where data were available) in the literature, all with underlying co-morbidities.

Conclusion: B. clausii probiotic preparations may cause prolonged bacteraemia, rendering patients with underlying co-morbidities as well as those with unrecognized risk factors vulnerable for significant infectious complications.

Keywords: Bacillus clausii; bacteraemia; probiotic.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bacillus clausiiProlonged BacteraemiaHarmful
Large
Bacillus clausii SNZ-1971Prolonged BacteraemiaHarmful
Large

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.